PTC THERAPEUTICS, INC. Earnings Per Share Diluted

Quick Answer

PTC THERAPEUTICS, INC. reported Earnings Per Share Diluted of $7.78 per share for the year ending 2025.

  • PTC THERAPEUTICS, INC. showed an increase of +264.5% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from PTC THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
  • XBRL data for this metric is available from 2011 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2012: $5,992.61 (loss) per share | Q2 2012: $48.29 per share | Q3 2012: $1,605.53 (loss) per share | Q4 2012: $1,380.13 (loss) per share | Q1 2013: $6,527.30 (loss) per share | Q2 2013: $5.51 (loss) per share | Q3 2013: $0.19 (loss) per share | Q4 2013: $0.75 (loss) per share | Q1 2014: $0.58 (loss) per share | Q2 2014: $0.86 (loss) per share | Q3 2014: $0.93 (loss) per share | Q4 2014: $0.84 (loss) per share | Q1 2021: $1.83 (loss) per share | Q2 2021: $1.68 (loss) per share | Q3 2021: $1.89 (loss) per share | Q1 2022: $1.78 (loss) per share | Q2 2022: $2.13 (loss) per share | Q3 2022: $1.53 (loss) per share | Q1 2023: $1.88 (loss) per share | Q2 2023: $2.66 (loss) per share | Q3 2023: $1.76 (loss) per share | Q1 2024: $1.20 (loss) per share | Q2 2024: $1.29 (loss) per share | Q3 2024: $1.39 (loss) per share | Q1 2025: $10.04 per share | Q2 2025: $0.83 (loss) per share | Q3 2025: $0.20 per share.
  • Over the full 11 years of available data (2011 to 2025), PTC THERAPEUTICS, INC.'s Earnings Per Share Diluted has grown by 71.0%.
  • Historical annual values: Fiscal year 2025: $7.78 per share | Fiscal year 2024: $4.73 (loss) per share | Fiscal year 2023: $8.37 (loss) per share | Fiscal year 2022: $7.79 (loss) per share | Fiscal year 2021: $7.43 (loss) per share | Fiscal year 2020: $6.64 (loss) per share | Fiscal year 2019: $4.27 (loss) per share | Fiscal year 2014: $2.97 (loss) per share | Fiscal year 2013: $5.18 (loss) per share | Fiscal year 2012: $42.50 per share | Fiscal year 2011: $4.55 per share.
  • Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: